Liminal BioSciences Inc. PFSCF

RE:RE:RE:RE:RE:RE:RE:It's Friday shorties ! better cover before the weekend,

[himmler]

This is an old article thats been posted before (last month) I know,but it is worth repeating...Mac whirter states that this year will be a loss,but 2019 is expected to break even...if PLI does break even then..we will have a very good chance of survival WITHOUT ..further dilution.
Interesting year this one will be.

Prometic Life Sciences Inc.(PLI-T)  January 5, 2018     The near to intermediate term is a bit of a challenge. They have technology to extract proteins from a bag of plasma. Their specialty is that they require a lot less CapX and operating costs to do it, and can end up getting much higher yields. The current process, which is over 40 years old, is maximized and optimized for something totally different in the proteins they were getting. They have approval to get plasminogen. Spending a ton of money to go through the formal drug testing process. It’s not expected to earn any money in 2018, but a loss of $.13 a share. Expected to break even in 2019. BIOTECHNOLOGY/PHARMACEUTICAL  0   0  0

Robert McWhirter President, Selective Asset Mana...    $1.680  No

Prometic Life Sciences Inc.(PLI-T)  January 5, 2018     The near to intermediate term is a bit of a challenge. They have technology to extract proteins from a bag of plasma. Their specialty is that they require a lot less CapX and operating costs to do it, and can end up getting much higher yields. The current process, which is over 40 years old, is maximized and optimized for something totally different in the proteins they were getting. They have approval to get plasminogen. Spending a ton of money to go through the formal drug testing process. It’s not expected to earn any money in 2018, but a loss of $.13 a share. Expected to break even in 2019. BIOTECHNOLOGY/PHARMACEUTICAL  0   0  0

Robert McWhirter President, Selective Asset Mana...    $1.680  No